China’s Yuanxin Technology nets $465m funding from Tencent, Sequoia, others February 9, 2021 Beijing Yuanxin Technology Co., Ltd, a specialist in digital healthcare and chain pharmacies, has raised 3 billion yuan ($465 million) in a Series E round co-led by existing investors Tencent and Sequoia Capital China. The round attracted a slew of investors from primary and secondary markets, according to a company statement on Tuesday. Existing investors including state-backed CITIC Group’s brokerage firm CITIC Securities, Qiming Venture Partners, Index Capital, and Kunling Capital re-upped in the round, while new investors who participated included CICC Capital, New York-based fund manager OrbiMed, Noah Holdings’ alternative asset manager Gopher Asset Management, and E Fund.